Management of Volume Overload HF Patients by Individual DSR Treatment adJustment-a clinicAl inVestigation of InfusatE2.0
NCT05965934
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
33
Enrollment
INDUSTRY
Sponsor class
Conditions
Heart Failure
Volume Overload
Interventions
DRUG:
Direct Sodium Removal Infusate 2.0
Sponsor
Sequana Medical N.V.